BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• 

  Cancer

  GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Type 2 Diabetes Patients: Study

  GLP-1 receptor agonists could reduce the risk of 10 obesity-associated cancers, such as meningioma, multiple myeloma and colorectal cancer, according to an analysis of electronic health records.

  July 8, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Legal

  Boehringer Ingelheim Loses Legal Challenge to IRA in Connecticut Federal Court Ruling

  A federal judge ruled last week that the U.S. government can use its economic standing as a bulk purchaser to negotiate for better deals, handing Boehringer Ingelheim a loss in its legal challenge to the Inflation Reduction Act.

  July 8, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Drug Development

  Roche Axes Phase II/III NSCLC Study as TIGIT Drug Loses to Keytruda-Chemo Combo

  Roche’s tiragolumab, when combined with its PD-L1 blocker Tecentriq, did not significantly improve progression-free and overall survival versus Keytruda and chemotherapy in patients with non-small cell lung cancer.

  July 8, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Series A

  Myricx Bio Raises $115M in Series A to Advance ADC With Lilly and Novo Backing
  
  

  The U.K.-based biotech is the latest to cash in on the hot antibody-drug conjugate space, closing a $115.5 million Series A round co-led by Novo Holdings and participation from Eli Lilly.
  
  

  July 8, 2024

   · 

  2 min read

   · 

  Tyler Patchen
• 

  Drug Development

  Patient Assistance Programs: A Source of Real-World Data?

  Patient assistance programs may actually be a two-way street, providing patients with drugs and companies with data.

  July 8, 2024

   · 

  3 min read

   · 

  Patience Asanga
• 

  Weight Loss

  Beyond GLP-1s: The Next Obesity Treatments

  Eli Lilly, Rivus Pharmaceuticals and more target different biological processes in hopes of generating higher-quality weight loss and avoiding metabolic issues.

  July 8, 2024

   · 

  6 min read

   · 

  Heather McKenzie
• 

  Business

  Lilly Pays $3.2B to Buy Morphic and Deepen Immunology, Gastro Portfolio

  Eli Lilly on Monday announced a $3.2 billion all-cash deal to purchase Morphic and its pipeline of oral integrin therapies in a move to expand the pharma’s presence in the autoimmune diseases space.

  July 8, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Mergers & Acquisitions

  Grifols Gets $6B Takeover Offer from Founding Family, Brookfield to Go Private

  The blood plasma pharma is considering a buyout offer from the founding family and asset manager Brookfield, which would delist the company from the Spanish and Nasdaq markets.

  July 8, 2024

   · 

  1 min read

   · 

  Kate Goodwin
• 

  FDA

  FDA CBER Director Dr. Peter Marks Discusses Industry Growth, Collaboration and Communication

  The groundwork being done in 2024 is building the foundation for global collaboration in the future.

  July 8, 2024

   · 

  1 min read

   · 

  Lori Ellis
• 

  Drug Development

  Drug Developers Tap the Immune System to Supercharge ADCs

  With the antibody drug conjugate market projected to hit $28 billion by 2028, some companies are looking to harness the drugs for immunotherapy.

  July 8, 2024

   · 

  7 min read

   · 

  Kate Goodwin